Canadian Bovine Mastitis Research Network, C.P. 5000, St-Hyacinthe, Québec, J2S 7C6, Canada.
J Dairy Sci. 2012 Nov;95(11):6483-502. doi: 10.3168/jds.2012-5594. Epub 2012 Sep 12.
Major mastitis pathogens such as Staphylococcus aureus, Streptococcus agalactiae, Streptococcus uberis, Streptococcus dysgalactiae, and the coliforms are usually considered more virulent and damaging to the udder than minor mastitis pathogens such as Corynebacterium bovis and coagulase-negative staphylococci (CNS). The current literature contains several studies detailing analyses with conflicting results as to whether intramammary infection (IMI) with the minor pathogens decreases, increases, or has no effect on the risk of a quarter acquiring a new intramammary infection (NIMI) with a major pathogen. To investigate the available scientific evidence regarding the effect of IMI with minor pathogens on the acquisition of NIMI with major pathogens, a systematic review and meta-analysis were conducted. The total extant English- and French-language literature in electronic databases was searched and all publications cited by relevant papers were investigated. Results from 68 studies were extracted from 38 relevant papers. Random-effects models were used to investigate the effects of CNS and C. bovis on acquisition of new IMI with any of the major pathogens, as well as individually for the minor pathogens and Staph. aureus. Significant heterogeneity among studies exists, some of which could be accounted for by using meta-regression. Overall, observational studies showed no effect, whereas challenge studies showed strong and significant protective effects, specifically when major pathogens were introduced into the mammary gland via methods bypassing the teat end. Underlying risk can account for several unmeasured factors, and studies with higher underlying risk found more protective effects of minor pathogens. Larger doses of challenge organisms reduced the protective effect of minor pathogens, and studies with more stringent diagnostic criteria for pathogen IMI identified less protection. Smaller studies (those utilizing fewer than 40 cows) also showed a greater protective effect than larger studies.
主要乳腺炎病原体,如金黄色葡萄球菌、无乳链球菌、停乳链球菌、乳房链球菌和大肠埃希菌通常被认为比次要乳腺炎病原体(如牛棒状杆菌和凝固酶阴性葡萄球菌(CNS))更具毒力和破坏性。目前的文献中有几项研究详细分析了次要病原体的乳腺内感染(IMI)是否降低、增加或对 quarters 获得新的主要病原体的乳腺内感染(NIMI)的风险没有影响,结果存在冲突。为了研究次要病原体的 IMI 对主要病原体的 NIMI 获得的影响,进行了系统评价和荟萃分析。在电子数据库中搜索了现有的英文和法文文献,并调查了相关文献中引用的所有出版物。从 38 篇相关文献中提取了 68 项研究的结果。使用随机效应模型研究了 CNS 和牛棒状杆菌对任何主要病原体获得新 IMI 的影响,以及对次要病原体和金黄色葡萄球菌的影响。研究之间存在显著的异质性,其中一些可以通过meta 回归来解释。总体而言,观察性研究没有效果,而挑战性研究显示出强烈而显著的保护作用,特别是当主要病原体通过绕过乳头末端的方法引入乳腺时。潜在的风险可以解释一些未测量的因素,并且具有较高潜在风险的研究发现次要病原体的保护作用更大。挑战生物体的较大剂量降低了次要病原体的保护作用,并且对病原体 IMI 具有更严格诊断标准的研究确定的保护作用较小。较小的研究(那些使用少于 40 头牛)也显示出比较大的研究更大的保护作用。